Selecting the optimal treatment for patients with chronic myeloid leukaemia after two prior lines of therapy
After watching this activity, participants should be better able to:
- Discuss the treatment for patients with CML after two prior lines of therapy in clinical practice
- Recall the latest clinical trial data for new and emerging treatments for patients with CML
- Evaluate the possible impact of new and emerging treatments on the management of patients with CML after two prior lines of therapy
In this activity, two chronic myeloid leukaemia (CML) experts, Prof. Simona Soverini and Dr Daniela Žáčková, discuss the selection of optimal treatment for patients with CML after two prior lines of therapy. They consider the mechanisms of action and the latest clinical efficacy data of current and emerging therapies, and how these may impact the management of CML after two prior lines of therapy. The discussion is guided by pre-canvassed questions provided by the haematology oncology clinical community.
To obtain the CE credit(s) from this activity, please complete this post-activity test.Claim Credit
You may also be interested in...
Robin Foà, ASH 2021: Measurable Residual Disease in the Management of Haematological Malignancies (PART TWO)
Jorge E Cortes, EHA 2019 – Advances in the Treatment and Management of Acute Myeloid Leukaemia
Optimising the Use of Ruxolitinib in Inadequately Controlled Polycythaemia Vera
A Comprehensive Overview of the Role of Azacitidine in the Management of Myelodysplastic Syndromes and Acute Myeloid Leukaemia
Facing clinical challenges associated with paroxysmal nocturnal haemoglobinuriaThis activity is CE/CME accredited
Selecting the optimal treatment for patients with chronic myeloid leukaemia after two prior lines of therapyThis activity is CE/CME accredited
Register to touchONCOLOGY for FREE
- 1000+ topical and insightful peer-reviewed journal articles
- 100+ hours of bite-sized congress highlights
- 8 major therapy areas packed with the latest scientific advances
- 150+ specialties offering learn-on-the-go medical education
- + Concise email updates and newsletters so you never miss out
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!